Brief: Paratek Pharmaceuticals Reports Third Quarter Results
12/11/2019 21:48
Nov 12 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS GENERATES NET REVENUES OF $3.9
MILLION
IN THE THIRD QUARTER OF 2019
* Q3 LOSS PER SHARE $1.00
* Q3 EARNINGS PER SHARE ESTIMATE $-1.05 -- REFINITIV IBES
DATA
* PARATEK PHARMACEUTICALS - SEES 2019 NUZYRA U.S. NET
PRODUCT
SALES WILL COME IN WITHIN RANGE OF $10.0 TO $13.0 MILLION;
LIKELY AT LOWER END OF RANGE
Source text for Eikon: ID:nGNXbzzStR
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million